The pace of history has always been moving forward. With the continuous transfer of global raw material drug production bases to Asia, China has already been at the forefront of the global raw material drug industry. Against this backdrop, QH Pharm continues to increase its investment in EHS and GMP, with a customer-centric approach and a series of products as the focus to develop a medium to long-term development strategy. With the corporate quality culture as the main line, it implements the safety and quality awareness of all employees, and always adheres to the path of green development. After more than ten years of efforts, we have achieved gratifying results in international certifications such as safety and quality. We have established long-term strategic partnerships with many internationally renowned multinational pharmaceutical companies, continuously improving our brand image and market share. Our corporate reputation has also been widely recognized by customers and society.

Chairman of the Board: Liu Xiangyi